A combination of systemic and intracranial anti-CD25 immunotherapy elicits a long-time survival in murine model of glioma

Journal of Oncology

Volumn , Issue , 2009, Pages

  El Andaloussi, Abdeljabar ^a   Poirier, Marie Denise ^a   Haban, Houda ^a  

^a UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER IMMUNOTHERAPY; CANCER RELAPSE; CANCER SURVIVAL; CELL EXPANSION; CELL MIGRATION; CONTROLLED STUDY; FEMALE; GLIOMA; IMMUNE RESPONSE; LYMPHOCYTE DEPLETION; MOUSE; NONHUMAN; REGULATORY T LYMPHOCYTE; SURVIVAL TIME;

EID: 77951692487     PISSN: 16878450     EISSN: 16878469     Source Type: Journal    
DOI: 10.1155/2009/963037     Document Type: Article

References (31)

1. El Andaloussi A., Han Y. U., Lesniak M. S., Prolongation of survival following depletion of CD4+CD25+ regulatory T cells in mice with experimental brain tumors Journal of Neurosurgery 2006 105 3 430 437
2. Rosenberg S. A., Spiess P., Lafreniere R., A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes Science 1986 233 4770 1318 1321 (Pubitemid 16002234)
3. Whiteside T. L., Parmiani G., Tumor-infiltrating lymphocytes: their phenotype, functions and clinical use Cancer Immunology Immunotherapy 1994 39 1 15 21 (Pubitemid 24216607)
4. El Andaloussi A., Lesniak M. S., An increase in CD4+CD25+ FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme Neuro-Oncology 2006 8 3 234 243 (Pubitemid 46542648)
5. Read S., Malmstrom V., Powrie F., Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25+CD4+ regulatory cells that control intestinal inflammation Journal of Experimental Medicine 2000 192 2 295 302 (Pubitemid 30470312)
6. Shimizu J., Yamazaki S., Takahashi T., Ishida Y., Sakaguchi S., Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance Nature Immunology 2002 3 2 135 142 (Pubitemid 34141443)
7. Greenwald R. J., Freeman G. J., Sharpe A. H., The B7 family revisited Annual Review of Immunology 2005 23 515 548
8. Valzasina B., Guiducci C., Dislich H., Killeen N., Weinberg A. D., Colombo M. P., Triggering of OX40 (CD134) on CD4+CD25+ T cells blocks their inhibitory activity: a novel regulatory role for OX40 and its comparison with GITR Blood 2005 105 7 2845 2851 (Pubitemid 40446278)
9. Zheng G., Wang B., Chen A., The 4-1BB costimulation augments the proliferation of CD4+CD25+ regulatory T cells Journal of Immunology 2004 173 4 2428 2434
10. Fontenot J. D., Rasmussen J. P., Williams L. M., Dooley J. L., Farr A. G., Rudensky A. Y., Regulatory T cell lineage specification by the forkhead transcription factor Foxp3 Immunity 2005 22 3 329 341
11. Hori S., Nomura T., Sakaguchi S., Control of regulatory T cell development by the transcription factor Foxp3 Science 2003 299 5609 1057 1061 (Pubitemid 36222930)
12. Ermann J., Hoffmann P., Edinger M., Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GVHD Blood 2005 105 5 2220 2226
13. Ochando J. C., Homma C., Yang Y., Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts Nature Immunology 2006 7 6 652 662 (Pubitemid 43797347)
14. Adu D., Cockwell P., Ives N. J., Shaw J., Wheatley K., Interleukin-2 receptor monoclonal antibodies in renal transplantation: meta-analysis of randomised trials British Medical Journal 2003 326 7393 789 791 (Pubitemid 36523583)
15. Shevach E. M., Regulatory T cells in autoimmmunity Annual Review of Immunology 2000 18 423 449
16. Mobley J. L., Dailey M. O., Regulation of adhesion molecule expression by CD8 T cells in vivo. I: differential regulation of gp90MEL-14 (LECAM-1), Pgp-1, LFA-1, and VLA-4 alpha during the differentiation of cytotoxic T lymphocytes induced by allografts Journal of Immunology 1992 148 8 2348 2356
17. Yu P., Lee Y., Liu W., Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors Journal of Experimental Medicine 2005 201 5 779 791
18. Jacob J. B., Kong Y.-C. M., Meroueh C., Control of Her-2 tumor immunity and thyroid autoimmunity by MHC and regulatory T cells Cancer Research 2007 67 14 7020 7027 (Pubitemid 47105551)
19. Von Boehmer H., Mechanisms of suppression by suppressor T cells Nature Immunology 2005 6 4 338 344 (Pubitemid 41716770)
20. El Andaloussi A., Lesniak M. S., CD 4 + CD 25 + FoxP3+ T-cell infiltration and heme oxygenase-1 expression correlate with tumor grade in human gliomas Journal of Neuro-Oncology 2007 83 2 145 152 (Pubitemid 46784987)
21. Grauer O. M., Nierkens S., Bennink E., CD4+FoxP3+ regulatory T cells gradually accumulate in gliomas during tumor growth and efficiently suppress antiglionia immune responses in vivo International Journal of Cancer 2007 121 1 95 105 (Pubitemid 46753856)
22. Fecci P. E., Sweeney A. E., Grossi P. M., Systemic anti-CD25 monoclonal antibody administration safely enhances immunity in murine glioma without eliminating regulatory T cells Clinical Cancer Research 2006 12 14 4294 4305
23. Zelenay S., Demengeot J., Comment on cutting edge: anti-CD25 monoclonal antibody injection results in the functional inactivation, not depletion, of CD4+CD25+ T regulatory cells Journal of Immunology 2006 177 4 2036 2037. author reply 2037-2038 (Pubitemid 44200956)
24. Stephens L. A., Anderton S. M., Comment on cutting edge: anti-CD25 monoclonal antibody injection results in the functional inactivation, not depletion, of CD4+CD25+ T regulatory cells Journal of Immunology 2006 177 4 2036 2037. author reply 2037-2038
25. Feuerer M., Beckhove P., Garbi N., Bone marrow as a priming site for T-cell responses to blood-borne antigen Nature Medicine 2003 9 9 1151 1157 (Pubitemid 37173699)
26. Cavanagh L. L., Bonasio R., Mazo I. B., Activation of bone marrow-resident memory T cells by circulating, antigen-bearing dendritic cells Nature Immunology 2005 6 10 1029 1037 (Pubitemid 41486188)
27. El Andaloussi A., Han Y., Lesniak M. S., Progression of intracranial glioma disrupts thymic homeostasis and induces T-cell apoptosis in vivo Cancer Immunology, Immunotherapy 2008 57 12 1807 1816
28. Peng Y., Laouar Y., Li M. O., Green E. A., Flavell R. A., TGF- regulates in vivo expansion of Foxp3-expressing CD4+CD25+ regulatory T cells responsible for protection against diabetes Proceedings of the National Academy of Sciences of the United States of America 2004 101 13 4572 4577 (Pubitemid 38437452)
29. Townsend S. E., Allison J. P., Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells Science 1993 259 5093 368 370
30. Ochsenbein A. F., Sierro S., Odermatt B., Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction Nature 2001 411 6841 1058 1064 (Pubitemid 32612331)
31. Melero I., Shuford W. W., Newby S. A., Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors Nature Medicine 1997 3 6 682 685 (Pubitemid 27264981)